Skip Navigation

Link to  the National Institutes of Health NIDA NEWS NIDA News RSS Feed
The Science of Drug Abuse and Addiction from the National Institute on Drug Abuse Keep Your Body Healthy
Go to the Home pageGo to the About Nida pageGo to the News pageGo to the Meetings & Events pageGo to the Funding pageGo to the Publications page
PhysiciansResearchersParents/TeachersStudents/Young AdultsEn Español Drugs of Abuse & Related Topics
 

 

New York Node


The NY Node is a consortium of academic centers, clinical programs and local and regional agencies with a long track record of fruitful collaboration in research, training, service delivery, policy-making, funding, and advocacy for addictive disorders. Key academic institutions include New York University, The Rockefeller University, the Nathan Kline Institute, and the NY Academy of Medicine. Our 7 CTPs provide a wide range of programs and treatment models, and services for more than 13,000 patients with extensive diagnostic, ethnic, and gender diversity. NY Node CTPs have been at the forefront of translational research and have made a number of pioneering achievements including the establishment of the first outpatient narcotic detoxification clinic, the first non-hospital-based methadone program, the first methadone-to-abstinence residential community, and the first social work field training in addiction.

 

Regional Research and Training Center

New York University, School of Medicine
550 First Avenue
New York, NY 10016


Principal Investigator


John Rotrosen, M.D.
Professor

Department of Psychiatry
NYU School of Medicine
423 East 23rd Street, 17W
New York, NY 10010
212-951-3294 (Voice)
John.Rotrosen@med.nyu.edu

Community Treatment Programs

Addiction Research and Treatment Corporation
Brooklyn, NY

Bellevue Hospital Center
New York, NY

Gracie Square Hospital
New York, NY

Greenwich House, Inc.
New York, NY

Lower Eastside Service Center(LESC)
New York, NY

Mount Sinai Medical Center
New York, NY

Odyssey House
New York, NY

VA New York Harbor Healthcare System
New York, NY


New York Protocol Involvement
PROTOCOL0002 Buprenorphine/Naloxone for Opiate Detoxification - OUTpatient
PROTOCOL0003 Suboxone (Buprenorphine/Naloxone) Taper: A Comparison of Two Schedules
PROTOCOL0005 Motivational Interviewing (MI)
PROTOCOL0007 Motivational Incentives - Methadone Clinics
PROTOCOL0008 A Baseline for Investigating Diffusion of Innovation
PROTOCOL0009 Smoking Cessation Treatment With Transdermal Nicotine Replacement Therapy In Substance Abuse Rehabilitation Programs
PROTOCOL0012 Characteristics of Screening, Evaluation, and Treatment of HIV/AIDS, Hepatitis C Viral Infection, and Sexually Transmitted Infections in Substance Abuse Treatment Progra
PROTOCOL0015 Women's Treatment for Trauma and Substance Use Disorders
PROTOCOL0016 Patient Feedback : A Performance Improvement Study in Outpatient Addiction Treatment
PROTOCOL0027 Starting Treatment with Agonist Replacement Therapies - START
PROTOCOL0029 A Pilot Study of Osmotic-Release Methylphenidate in Initiating and Maintaining Abstinence in Smokers with ADHD
PROTOCOL0030 Prescription Opioid Addiction Treatment Study (POATS)



 

 



NIDA Home | Site Map | Search | FAQs | Accessibility | Privacy | FOIA (NIH) | Employment | Print Version



National Institutes of Health logo_Department of Health and Human Services Logo The National Institute on Drug Abuse (NIDA) is part of the National Institutes of Health (NIH) , a component of the U.S. Department of Health and Human Services. Questions? See our Contact Information. Last updated on Monday, July 7, 2008. The U.S. government's official web portal